By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Gelteq Limited Ordinary Shares (GELS)

NASDAQ Currency in AUD
$1.50
+$0.15
+11.11%
Last Update: 11 Sept 2025, 20:00
$15.04M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.77 - $5.50
52 Week Range

GELS Stock Price Chart

Explore Gelteq Limited Ordinary Shares interactive price chart. Choose custom timeframes to analyze GELS price movements and trends.

GELS Company Profile

Discover essential business fundamentals and corporate details for Gelteq Limited Ordinary Shares (GELS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

Employees

7.00

CEO

Nathan Jacob Givoni

Description

Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.

GELS Financial Timeline

Browse a chronological timeline of Gelteq Limited Ordinary Shares corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

GELS Stock Performance

Access detailed GELS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run